Renin-Angiotensin System-Regulating Aminopeptidase Activities Are Modified in the Pineal Gland of Rats with Breast Cancer Induced by N-Methyl-Nitrosourea

REFERENCES

• Reiter R. J. The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev. 1980; 1(2)109–131, [CSA]
   PubMedGoogle Scholar
• Blask D E., Pelletier D. B.M., Hill S. M., Lemus-Wilson A., Grosso D. S., Wilson S. T., Wise M. E. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J. Cancer Res. Clin. Oncol. 1991; 117(6)526–532, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bartol I., Skorupa A. L., Scialfa J. H., Cipolla-Neto J. Pineal metabolic reaction to retinal photostimulation in ganglionectomized rats. Brain Res. 1997; 744(1)77–82, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Simonneaux V. Neuropeptides of the mammalian pineal gland. Neuroendocrinol. Lett. 1995; 17(2)115–130, [CSA]
   Web of Science ®Google Scholar
• Moller M., Ravault J. P., Cozzi B. The chemical neuroanatomy of the mammalian pineal gland: neuropeptides. Neurochem. Int. 1996; 28(1)23–33, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Baltatu O., Afeche S. C., Jose dos Santos S. H., Campos L. A., Barbosa R., Michelini L. C., Bader M., Cipolla-Neto J. Locally synthesized angiotensin modulates pineal melatonin generation. J. Neurochem. 2002; 80(2)328–334, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haulica I., Branisteanu D. D., Rosca V., Stratone A., Berbeleu V., Balan G., Ionescu L. A renin-like activity in pineal gland and hypophysis. Endocrinology 1975; 96(2)508–510, [CSA]
   PubMed Web of Science ®Google Scholar
• Chansel D., Ardaillou R. Active metabolites derived from angiotensin II. Nephrologie 1998; 19(7)427–432, [CSA]
   PubMedGoogle Scholar
• Beynon R., Bond J. S. Proteolityc Enzymes, 2nd edition, R. Benyon, J. S. Bonds. Oxford University. 2001
   Google Scholar
• Ward P. E., Benter I. F., Dick L., Wilk S. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem. Pharmacol. 1990; 40(8)1725–1732, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rivera E. S., Andrade N., Martin G., Melito G., et al. Induction of mammary tumors in rat by intraperitoneal inyection of NMU, histopathology and estral cycle influence. Cancer Lett. 1994; 86(2)223–228, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• García M. J., Martínez-Martos J. M., Mayas M. D., Carrera M. P., Ramírez-Expósito M. J. Hormonal status modifies renin-angiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus-pituitary-adrenal axis of male mice. Life Sci. 2003; 73(5)525–538, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carrera M. P., Ramírez-Expósito M. J., Valenzuela M. T., García M. J., Mayas M. D., Martínez-Martos J. M. Glutamyl- but not aspartyl- aminopeptidase activity is modified in serum of N-methyl nitrosourea-induced rat mammary tumours. Anticancer Res 2004; 24(2B)801–805, [CSA]
   PubMed Web of Science ®Google Scholar
• Tobe H., Kojima F., Aoyagi T., Umezawa H. Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim. Biophys Acta 1980; 613(1)459–468, [CSA]
   PubMedGoogle Scholar
• Baltatu O., Lippoldt A., Hansson A., Ganten D., Bader M. Local renin-angiotensin system in the pineal gland. Brain Res. Mol. Brain Res. 1998; 54(2)237–242, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Mizuno K., Hashimoto S., Ojima M., Kunii N., Tani M., Niimura S., Watari H., Fukuchi S. Immunoreactive renin in human brain: distribution and properties. Jpn. Circ. J. 1985; 49(9)1005–1011, [CSA]
   PubMedGoogle Scholar
• de Agostini A., Reinharz A., Vallotton M. B. Renin-like and cathepsin D activities in bovine pineal glands. Neuroendocrinology. 1982; 35(6)457–463, [CSA]
   PubMed Web of Science ®Google Scholar
• Nahmod V. E., Balda M. S., Pirola C. J., Finkielman S., Gejman P. V., Cardinali D. P. Circadian rhythm and neural regulation of rat pineal angiotensin converting enzyme. Brain Res. 1982; 236(1)216–220, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bartsch C., Bartsch H., Lippert T. H. The pineal gland and cancer: Facts, hypothesis and perspectives. Cancer J. 1992; 5(4)194–199, [CSA]
   Web of Science ®Google Scholar
• Blask D. E. Melatonin in Oncology. Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, H.-S. Yu, R. J. Reiter. CRC Press, Boca Raton, FL 1993; 447–475
   Google Scholar
• Reiter R. J. The Pineal Gland and Cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, TübingenGermany 1988; 41–64
   Google Scholar
• Cohen M., Lippman M., Chabner B. Role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978; 14(2)814–816, [CSA], [CROSSREF]
   Google Scholar
• Blask D. E., Hill S. M. Melatonin. Clinical Perspectives, A. Miles, D. R.S. Philbrick, C. Thompson. Oxford University Press, New York 1988; 128–173
   Google Scholar
• Kothari L. S., Shah P. N., Mhatre M. C. Pineal ablation in varying photoperiods and the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary cancer in rats. Cancer Lett. 1984; 22(1)99–102, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shah P. N., Mhatre M. C., Kothari L. S. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res. 1984; 44(8)3403–3407, [CSA]
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front. Neuroendocrinol. 1995; 16(4)383–415, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reiter R. J., Tan D. X., Poeggeler B., Chen L. D., Menéndez-Pelaez A. In Advances in Pineal Research: 7, G. J.M. Maestroni, A. Conti, R. J. Reiter. Libbey, London 1994; 211–228
   Google Scholar
• Tan D., Reiter R. J., Chen L. D., Poeggeler B., Manchester L. C., Barlow-Walden L. R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994; 15(2)215–218, [CSA]
   PubMed Web of Science ®Google Scholar
• Haulica I., Petrescu G., Uluitu M., Rosca V., Slatineanu S. Influence of angiotensin II on dog pineal serotonin content. Neurosci. Lett. 1980; 18(3)329–332, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Finocchiaro L. M., Goldstein D. J., Finkielman S., Nahmod V. E. Interaction of angiotensin II with the cholinergic and noradrenergic systems in the rat pineal gland: regulation of indole metabolism. J. Endocrinol. 1990; 126(1)59–66, [CSA]
   PubMed Web of Science ®Google Scholar
• Bartsch C., Bartsch H. Melatonin in cancer patients and in tumor-bearing animals. Adv. Exp. Med. Biol. 1999; 467: 247–264, [CSA]
   PubMed Web of Science ®Google Scholar
• Zini S., Fournie-Zaluski M. C., Chauvel E., Roques B. P., Corvol P., Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA 1996; 93(21)11968–11973, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar